Trial intelligence / Profile preview

Safety and Efficacy of Benzoyl Peroxide/Clindamycin and Tazarotene Combination in Acne Vulgaris

NCT00713609Phase 2Completed

Sponsor
GSK
Start
Jun 2008
Primary completion
Mar 2009
Modality
Transdermal Patches, Orthosteric Ligands, Hydrogel Systems
Countries
1
01

Overview

A Phase 2 trial of benzoyl peroxide + sulfur, clindamycin, tazarotene in acne vulgaris, sponsored by GSK. Started Jun 2008; status: completed.

02

Drugs

benzoyl peroxide + sulfurclindamycintazarotene
03

Conditions

acne vulgaris

Beyond the preview

Go deeper on NCT00713609.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00713609.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call